<DOC>
	<DOCNO>NCT00102934</DOCNO>
	<brief_summary>Drug resistance may develop HIV infected patient take anti-HIV drug , patient well continue take . The purpose study test effectiveness short , intensified course anti-HIV drug control HIV infection adult virus resistant multiple drug .</brief_summary>
	<brief_title>Treatment Intensification HIV Infected Patients With Multi-Drug Resistant Virus</brief_title>
	<detailed_description>While HIV infect patient take highly active antiretroviral therapy ( HAART ) , drug-resistant HIV may emerge ; however , observe HIV viral load HAART usually low baseline level . Expansion T cell population early HAART may explain phenomenon . It hop short aggressive HAART regimen treatment-experienced patient drug-resistant virus produce immune cell well control drug-resistant virus . This study determine 6-month HAART regimen intensify enfuvirtide ( T-20 ) effective elicit strong immune response drug-resistant virus . This study last 48 week . All participant receive T-20 part HAART intensification regimen ; HAART T-20 provide study . There 17 study visit . Prior begin treatment intensification , participant weekly study visit three week . Once treatment intensification start , participant follow weekly four week , weekly four week treatment intensification , monthly thereafter . Blood collection occur visit .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>HIV viral load 1000 copies/ml On stable antiretroviral therapy Have multidrug resistance Require immunomodulatory drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>HIV</keyword>
	<keyword>Drug Resistance</keyword>
	<keyword>Viral Fitness</keyword>
	<keyword>HIV Specific Immunity</keyword>
	<keyword>T Cell Activation</keyword>
	<keyword>Drug Resistant Viremia</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>